1,062
Participants
Start Date
January 7, 2015
Primary Completion Date
July 15, 2020
Study Completion Date
July 15, 2020
alemtuzumab GZ402673
Pharmaceutical form:concentrate for solution for infusion Route of administration: intravenous
Investigational Site Number 5005, Brussels
Investigational Site Number 5301, København Ø
Investigational Site Number 2006, Westmead
Investigational Site Number 2012, Kogarah
Investigational Site Number 5001, Leuven
Investigational Site Number 2002, Parkville
Investigational Site Number 2003, Melbourne
Investigational Site Number 2001, Heidelberg
Investigational Site Number 2013, Auchenflower
Investigational Site Number 5004, Esneux
Investigational Site Number 2005, Southport
Investigational Site Number 2011, Hobart
Investigational Site Number 5302, Aarhus N
Investigational Site Number 1026, New York
Investigational Site Number 4106, Orbassano (TO)
Investigational Site Number 1081, Mineola
Investigational Site Number 1160, Patchogue
Investigational Site Number 4801, Prague
Investigational Site Number 1053, Syracuse
Investigational Site Number 4602, Berlin
Investigational Site Number 3102, México
Investigational Site Number 1015, Rochester
Investigational Site Number 4609, Hennigsdorf
Investigational Site Number 1097, Allentown
Investigational Site Number 4610, Rostock
Investigational Site Number 4102, Gallarate (VA)
Investigational Site Number 1037, Vienna
Investigational Site Number 4622, Hamburg
Investigational Site Number 1082, Winston-Salem
Investigational Site Number 1095, Chapel Hill
Investigational Site Number 4303, Madrid
Investigational Site Number 4305, Málaga
Investigational Site Number 4605, Hanover
Investigational Site Number 3105, Chihuahua City
Investigational Site Number 1078, Jacksonville
Investigational Site Number 1059, Maitland
Investigational Site Number 1034, Sunrise
Investigational Site Number 1005, Tampa
Investigational Site Number 1049, Tampa
Investigational Site Number 1173, Sarasota
Investigational Site Number 1055, Franklin
Investigational Site Number 1042, Nashville
Investigational Site Number 1009, Knoxville
Investigational Site Number 1163, Cordova
Investigational Site Number 1021, Louisville
Investigational Site Number 1039, Lexington
Investigational Site Number 4304, Seville
Investigational Site Number 4701, Gothenburg
Investigational Site Number 4802, Teplice
Investigational Site Number 1035, Cleveland
Investigational Site Number 1058, Uniontown
Investigational Site Number 1024, Indianapolis
Investigational Site Number 1001, Fort Wayne
Investigational Site Number 1020, Detroit
Investigational Site Number 1054, Traverse City
Investigational Site Number 4804, Hradec Králové
Investigational Site Number 1017, Des Moines
Investigational Site Number 5501, Ramat Gan
Investigational Site Number 1008, Northbrook
Investigational Site Number 4634, Frankfurt am Main
Investigational Site Number 1092, St Louis
Investigational Site Number 1084, Kansas City
Investigational Site Number 4803, Brno
Investigational Site Number 1022, Kansas City
Investigational Site Number 1083, Lenexa
Investigational Site Number 1067, Oklahoma City
Investigational Site Number 1018, Houston
Investigational Site Number 1002, Round Rock
Investigational Site Number 1027, Fort Collins
Investigational Site Number 4608, München
Investigational Site Number 1031, Phoenix
Investigational Site Number 1171, Phoenix
Investigational Site Number 1090, Tucson
Investigational Site Number 1014, Albuquerque
Investigational Site Number 4702, Umeå
Investigational Site Number 1093, Pasadena
Investigational Site Number 1152, Fullerton
Investigational Site Number 1040, Berkeley
Investigational Site Number 1068, Seattle
Investigational Site Number 6009, Kazan'
Investigational Site Number 6001, Moscow
Investigational Site Number 6005, Moscow
Investigational Site Number 3006, Porto Alegre
Investigational Site Number 1086, Cullman
Investigational Site Number 1061, Wellesley
Investigational Site Number 1028, Worcester
Investigational Site Number 1025, Ann Arbor
Investigational Site Number 1073, Teaneck
Investigational Site Number 1057, Providence
Investigational Site Number 1046, San Antonio
Investigational Site Number 2009, Sydney
Investigational Site Number 5505, Tel Aviv
Investigational Site Number 6003, Moscow
Investigational Site Number 6006, Nizhny Novgorod
Investigational Site Number 6010, Pyatigorsk
Investigational Site Number 6002, Saint Petersburg
Investigational Site Number 6004, Saint Petersburg
Investigational Site Number 6008, Saint Petersburg
Investigational Site Number 6013, Samara
Investigational Site Number 6016, Ufa
Investigational Site Number 6102, Kharkiv
Investigational Site Number 6104, Kiev
Investigational Site Number 6103, Lviv
Investigational Site Number 03208, CABA
Investigational Site Number 3002, Recife
Investigational Site Number 3001, São Paulo
Investigational Site Number 3003, São Paulo
Investigational Site Number 1102, Calgary
Investigational Site Number 1105, Gatineau
Investigational Site Number 1104, Greenfield Park
Investigational Site Number 1109, Kingston
Investigational Site Number 1110, London
Investigational Site Number 1101, Ottawa
Investigational Site Number 1106, Vancouver
Investigational Site Number 4607, Dresden
Investigational Site Number 4613, Wermsdorf
Investigational Site Number 4112, Cagliari
Investigational Site Number 4110, Roma
Investigational Site Number 4202, Sittard-Geleen
Investigational Site Number 4902, Krakow
Investigational Site Number 4901, Lodz
Investigational Site Number 4903, Lublin
Investigational Site Number 4904, Poznan
Investigational Site Number 4905, Warsaw
Investigational Site Number 4301, Barcelona
Investigational Site Number 4004, Bristol
Investigational Site Number 4001, Cambridge
Investigational Site Number 4005, Cardiff
Investigational Site Number 4006, London
Investigational Site Number 4008, Salford
Investigational Site Number 4007, Sheffield
Genzyme, a Sanofi Company
INDUSTRY